Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “1- Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03799835
What this trial is testing

Atezolizumab Plus One-year BCG Bladder Instillation in BCG-naive High-risk Non-muscle Invasive Bladder Cancer Patients

Who this might be right for
Bladder Cancer
UNICANCER 517
Testing effectiveness (Phase 2)Looking for participantsNCT04752826
What this trial is testing

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

Who this might be right for
Advanced MalignanciesOvarian CancerT-cell Lymphoma+1 more
BioInvent International AB 250
Testing effectiveness (Phase 2)Ended earlyNCT04402385
What this trial is testing

Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)

Who this might be right for
Pre-EclampsiaStage 1 HypertensionElevated Blood Pressure
Yale University 50
Early research (Phase 1)Study completedNCT01101061
What this trial is testing

A Single-dose Study Evaluating Romosozumab (AMG 785) in Healthy Postmenopausal Japanese and Non-Japanese Women

Who this might be right for
Osteopenia
Amgen 31
Not applicableStudy completedNCT01892319
What this trial is testing

An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 2,446
Testing effectiveness (Phase 2)Study completedNCT02951767
What this trial is testing

Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)

Who this might be right for
Bladder Cancer
Hoffmann-La Roche 119
Early research (Phase 1)UnknownNCT04620109
What this trial is testing

Clinical Evaluation of Safety and Tolerability of KDR2-2 Eye Drops in Healthy Volunteers With Pharmacokinetic Assessment

Who this might be right for
Corneal Neovascularization
Guangzhou HuiBoRui Biological Pharmaceutical Technology Co. Ltd 62
Early research (Phase 1)Study completedNCT05225857
What this trial is testing

A First-in-Human Study Evaluating AGA2118 in Men and Postmenopausal Women

Who this might be right for
Osteoporosis
Angitia Biopharmaceuticals 90
Early research (Phase 1)Study completedNCT04327089
What this trial is testing

Study to Evaluate the Pharmacokinetics and Drug-Drug Interactions of Setanaxib in Healthy Adult Male and Female Subjects

Who this might be right for
Phase 1
Calliditas Therapeutics AB 64
Not applicableUnknownNCT01814150
What this trial is testing

The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel

Who this might be right for
Metastatic Lung CancerMetastatic Breast CancerMetastatic Gastric Cancer+2 more
Gottfried Maya 200
Early research (Phase 1)Study completedNCT01591850
What this trial is testing

A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers

Who this might be right for
Healthy Volunteer
Hoffmann-La Roche 51
Large-scale testing (Phase 3)UnknownNCT02584478
What this trial is testing

Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)

Who this might be right for
Endometrial CarcinomaOvarian CarcinomaFallopian Tube Carcinoma+2 more
Advenchen Laboratories, LLC 294
Early research (Phase 1)Study completedNCT05339633
What this trial is testing

Study in Healthy Adult Female Subjects

Who this might be right for
Mass Balance Recovery
InventisBio Co., Ltd 8
Early research (Phase 1)Study completedNCT03097016
What this trial is testing

Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Insufficiency
Celgene 48
Post-approval studies (Phase 4)Study completedNCT01315314
What this trial is testing

Effect of Glucose Degradation Products (GDP) on Endothelial Dysfunction

Who this might be right for
Kidney Failure, ChronicDisorders Associated With Peritoneal Dialysis
Kyungpook National University Hospital 146
Early research (Phase 1)Study completedNCT05963932
What this trial is testing

Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Adult Participants

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 60
Testing effectiveness (Phase 2)Study completedNCT01091428
What this trial is testing

Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer

Who this might be right for
Ovarian CarcinomaFallopian Tube CancerPeritoneal Cancer+1 more
Millennium Pharmaceuticals, Inc. 191
Not applicableStudy completedNCT00060021
What this trial is testing

Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation

Who this might be right for
Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT05918614
What this trial is testing

Determine the Effect of 500 mg Oral Dose of KD025 in Healthy Male and Post-menopausal Female Subjects

Who this might be right for
Immune System Disorder (Healthy Volunteer)
Kadmon, a Sanofi Company 8
Early research (Phase 1)Active Not RecruitingNCT06734234
What this trial is testing

Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Kidney Disease
GlaxoSmithKline 86
Next Page